Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Chen Insider Profile
4 Followers
Peter Chen, Executive at Inceptus Capital, holds 840.00K shares in Inceptus Capital (Ticker: ICPPF), holds 767.86K shares in Avricore Health (Ticker: AVCRF). Most recently, Peter Chen Bought ― shares of Inceptus Capital on Nov 13, 2017 for an estimated value of 4.00K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-10.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Former
Roles that Peter Chen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter Chen
Peter Chen's Trading History
Inceptus Capital
Nov 13, 2017
―
Informative Buy
4.00K
$135.24K
Avricore Health
Jan 17, 2011
Former
Informative Buy
30.00K
$51.45K
List of latest transactions for each holding click on a transaction to see Peter Chen's performance on stock
You May Also Like
Peter Chen insider profile FAQ
What is the percentage of profitable transactions made by Peter Chen?
The percentage of profitable transactions made by Peter Chen is 50%.
What is the average return per transaction made by Peter Chen?
The average return per transaction made by Peter Chen is -10.90%.
What stocks does Peter Chen hold?
Peter Chen holds: ICPPF, AVCRF stocks.
What was Peter Chen’s latest transaction?
Peter Chen latest transaction was an Informative Buy of $4.00K.
What was Peter Chen's most profitable transaction?
Peter Chen’s most profitable transaction was an Informative Sell of AVCRF stock on November 13, 2009. The return on the trade was 76.20%.
What is Peter Chen's role in Inceptus Capital?
Peter Chen's role in Inceptus Capital is Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.